Center for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, United States.
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Internal Medicine, Davis Heart & Lung Research Institute, The Ohio State University, Columbus, OH, United States.
Front Immunol. 2018 Mar 26;9:561. doi: 10.3389/fimmu.2018.00561. eCollection 2018.
is a remarkably infectious facultative intracellular bacterium of macrophages that causes tularemia. Early evasion of host immune responses contributes to the success of as a pathogen. entry into human monocytes and macrophages is mediated by the major phagocytic receptor, complement receptor 3 (CR3, CD11b/CD18). We recently determined that despite a significant increase in macrophage uptake following C3 opsonization of the virulent Type A spp. Schu S4, this phagocytic pathway results in limited pro-inflammatory cytokine production. Notably, MAP kinase/ERK activation is suppressed immediately during C3-opsonized Schu S4-CR3 phagocytosis. A mathematical model of CR3-TLR2 crosstalk predicted early involvement of Ras GTPase-activating protein (RasGAP) in immune suppression by CR3. Here, we link CR3-mediated uptake of opsonized Schu S4 by human monocytes and macrophages with inhibition of early signal 1 inflammasome activation, evidenced by limited caspase-1 cleavage and IL-18 release. This inhibition is due to increased RasGAP activity, leading to a reduction in the Ras-ERK signaling cascade upstream of the early inflammasome activation event. Thus, our data uncover a novel signaling pathway mediated by CR3 following engagement of opsonized virulent to limit inflammasome activation in human phagocytic cells, thereby contributing to evasion of the host innate immune system.
是一种具有感染力的兼性细胞内细菌,可引起野兔热。早期逃避宿主免疫反应有助于 作为病原体的成功。进入人单核细胞和巨噬细胞是由主要吞噬受体,补体受体 3(CR3,CD11b/CD18)介导的。我们最近确定,尽管在对毒力型 A spp.的 C3 调理后,巨噬细胞摄取量显著增加。施氏 S4,这种吞噬途径导致有限的促炎细胞因子产生。值得注意的是,MAP 激酶/ERK 激活在 C3-调理的 Schu S4-CR3 吞噬作用期间立即受到抑制。CR3-TLR2 串扰的数学模型预测 Ras GTPase 激活蛋白(RasGAP)在 CR3 介导的免疫抑制中的早期参与。在这里,我们将人单核细胞和巨噬细胞中调理的 Schu S4 的 CR3 介导摄取与早期信号 1 炎症小体激活的抑制联系起来,这表现在 caspase-1 切割和 IL-18 释放有限。这种抑制是由于 RasGAP 活性增加,导致早期炎症小体激活事件上游的 Ras-ERK 信号级联减少。因此,我们的数据揭示了一种新型信号通路,该通路在结合调理后的毒力后,通过 CR3 介导,限制人吞噬细胞中炎症小体的激活,从而有助于逃避宿主固有免疫系统。